February 2, 2026

Mettler-Toledo International (MTD) Stock Analysis: A Precision Player with a 9.53% Upside Potential

Mettler-Toledo International Inc. (NYSE: MTD), a leader in the precision instruments sector within the healthcare industry, is drawing attention from investors with its robust market presence and a notable potential..

Pfizer, Inc. (PFE) Stock Analysis: Exploring the 6.59% Dividend Yield and Potential Upside

As an iconic name in the healthcare industry, Pfizer, Inc. (NYSE: PFE) continues to draw significant attention from investors, not just for its groundbreaking contributions to the pharmaceutical sector but..

Boston Scientific Corporation (BSX) Stock Analysis: A Promising 33% Upside for Healthcare Investors

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $138.71 billion, the company is..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the 3.95% Potential Upside Amid Healthcare Sector Shifts

Molina Healthcare Inc (NYSE: MOH), a pivotal player in the healthcare plans industry, continues to catch the eyes of investors with its robust market presence and strategic focus on managed..

Bristol-Myers Squibb (BMY) Stock Analysis: A Solid Dividend Payout Amidst Modest Growth Potential

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, continues to be a cornerstone for many portfolios with its robust dividend yield and promising drug pipeline. With a..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 10.51% Potential Upside

Labcorp Holdings Inc. (NYSE: LH), a leader in the healthcare sector’s diagnostics and research industry, presents a compelling case for investors as it continues to drive growth and offer potential..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: A Promising 15% Upside as Analysts Rally Behind Biotech Giant

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a leading force in the biotechnology sector, renowned for its innovative approach to developing and commercializing medicines addressing a wide array of diseases. Headquartered..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with a 13.73% Upside Potential

McKesson Corporation (NYSE: MCK), a titan in the healthcare sector, continues to show promising growth prospects, captivating investors with its strong market presence and potential upside of 13.73%, according to..

Alnylam Pharmaceuticals (ALNY): Investor Outlook with a 41% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, has been making waves with its revolutionary approach to therapeutics based on ribonucleic acid interference (RNAi). As of the..

Haleon plc (HLN) Investor Outlook: Exploring a Potential 12.92% Upside in the Healthcare Sector

Haleon plc (HLN), a stalwart in the healthcare sector, presents a unique proposition for investors seeking exposure to the burgeoning field of consumer healthcare products. With a robust market capitalization..

CVS Health Corporation (CVS) Stock Analysis: Evaluating a 27% Upside Amidst Strong Buy Ratings

Investors eyeing the healthcare sector should take note of CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare plans industry. With a substantial market capitalization of $94.6 billion,..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 21.34% Upside Potential in the Healthcare Sector

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a formidable market capitalization of $180.75 billion,..

Medtronic plc (MDT) Stock Analysis: A Healthcare Titan with a 7.65% Upside Potential

Medtronic plc (NYSE: MDT), a stalwart in the healthcare sector, stands as a beacon for investors seeking stability and growth within the medical devices industry. Headquartered in Ireland, Medtronic boasts..

Zoetis Inc. (ZTS) Stock Report: 23.75% Potential Upside and Strong Buy Ratings in Animal Health Sector

Zoetis Inc. (ZTS), a leading player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, commands significant attention from investors keen on tapping into the robust..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a Strong Return on Equity and Steady Dividend Yield

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to be a mainstay for investors seeking stability and growth in the volatile drug manufacturing industry. With a..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant Shows 11% Upside Potential and Robust Earnings

Cencora, Inc. (NYSE: COR), a titanic entity in the healthcare sector, is making waves in the medical distribution industry. With a market capitalization of $69.88 billion, this U.S.-based company has..

The Cigna Group (CI) Stock Analysis: Unveiling a 19.27% Potential Upside for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare plans industry, offers a range of insurance and related services primarily in the United States. With a current market capitalization..

Eli Lilly (LLY) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Highlight Growth Potential

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to captivate investor interest with its robust financial performance and strategic partnerships. With a market capitalization nearing..

AbbVie Inc. (ABBV) Stock Analysis: Navigating a 9.12% Potential Upside in the Healthcare Sector

AbbVie Inc. (NYSE: ABBV), a stalwart in the healthcare sector, is capturing investor attention with its substantial market cap of $394.14 billion and a promising potential upside of 9.12%. As..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with a Strong Return on Equity and Growth Potential

Novo Nordisk A/S (NVO) stands as a formidable player in the healthcare sector, specializing in drug manufacturing. Headquartered in Bagsvaerd, Denmark, the company is renowned for its focus on diabetes,..

Search

Funds

February 2, 2026

Search

Funds

February 2, 2026

FTSE 100

Funds